
Volume 10, Supplement 1 (Mar 2019)
Volume 10, Supplement 1 (Mar 2019)
Immuno-Oncology Therapy Essentials: Proactive Management of Immune-Related Adverse Events
This supplement, certified for CME/CE/CPE credit, is jointly provided by:
Meeting the Challenge of Immune-Related Adverse Events With Optimized Telephone Triage and Dedicated Oncology Acute Care
March 17, 2019
PD-1/PD-L1 Inhibitors for Non–Small Cell Lung Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management
March 17, 2019
Checkpoint Inhibitor Immunotherapy for Head and Neck Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management
March 17, 2019
Immune-Related Adverse Events From Immunotherapy: Incorporating Care Step Pathways to Improve Management Across Tumor Types
March 17, 2019
Advertisement
Current Issue


Vol 16
No 2
Mar/Apr 2025
Survivorship and Advance Care Planning in Cancer
Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO
March 17, 2025
Decreasing Pain Intensity in Adult Patients With Cancer Through Music Therapy
Leighann B. Montoya, DNP, APRN, AGPC-BC, Dorothie Durosier Mertilus, PhD, DNP, APRN, AGNP-C
March 17, 2025
Digging into the Cause of Drug-Induced Thrombocytopenia A Case Report
Vivian A. Pham, PharmD, Christopher Selby, PharmD, BCOP
March 17, 2025